Chicago Capital’s GSK GSK Stock Holding History

Chicago Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$420K	Hold	8,015	–	–	0.01%	290
2026 Q1	$442K	Hold	8,015	–	–	0.01%	271
2025 Q4	$393K	Buy	8,015 +728	+10%	+$34K	0.01%	284
2025 Q3	$315K	Hold	7,287	–	–	0.01%	297
2025 Q2	$280K	Hold	7,287	–	–	0.01%	307
2025 Q1	$282K	Sell	7,287 -100	-1%	-$3.66K	0.01%	295
2024 Q4	$250K	Buy	7,387 +100	+1%	+$3.6K	0.01%	292
2024 Q3	$298K	Hold	7,287	–	–	0.01%	266
2024 Q2	$281K	Hold	7,287	–	–	0.01%	271
2024 Q1	$312K	Sell	7,287 -187	-3%	-$7.71K	0.01%	252
2023 Q4	$277K	Hold	7,474	–	–	0.01%	243
2023 Q3	$271K	Buy	7,474 +187	+3%	+$6.64K	0.01%	197
2023 Q2	$260K	Buy	7,287 +187	+3%	+$6.71K	0.01%	199
2023 Q1	$253K	Hold	7,100	–	–	0.01%	203
2022 Q4	$249K	Hold	7,100	–	–	0.01%	201
2022 Q3	$209K	Sell	7,100 -128	-2%	-$4.85K	0.01%	218
2022 Q2	$393K	Hold	7,228	–	–	0.02%	182
2022 Q1	$394K	Hold	7,228	–	–	0.02%	194
2021 Q4	$398K	Hold	7,228	–	–	0.01%	197
2021 Q3	$345K	Hold	7,228	–	–	0.01%	204
2021 Q2	$360K	Hold	7,228	–	–	0.01%	203
2021 Q1	$322K	Sell	7,228 -1,589	-18%	-$72.1K	0.01%	205
2020 Q4	$406K	Hold	8,817	–	–	0.02%	180
2020 Q3	$415K	Hold	8,817	–	–	0.02%	169
2020 Q2	$450K	Hold	8,817	–	–	0.03%	158
2020 Q1	$418K	Hold	8,817	–	–	0.03%	147
2019 Q4	$518K	Hold	8,817	–	–	0.03%	157
2019 Q3	$470K	Hold	8,817	–	–	0.03%	161
2019 Q2	$441K	Buy	8,817 +3,642	+70%	+$183K	0.03%	168
2019 Q1	$270K	Buy	+5,175	New	+$259K	0.02%	188

Other funds holding GSK

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

MHI

Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.82B AUM

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

FVWA

Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return

Chicago Capital's GSK Position: Q2 2026 in Review

Chicago Capital held its GSK (GSK) position steady in Q2 2026 at 8,015 shares worth $420K. The position accounts for 0.01% of the portfolio, ranked #290.

Chicago Capital first reported a position in GSK in Q1 2019 and has held it in 30 quarters since. The position peaked at $518K in Q4 2019. 439 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Chicago Capital held 8,015 shares of GSK worth $420K as of Q2 2026.
Chicago Capital left its GSK share count unchanged in Q2 2026.
GSK made up 0.01% of Chicago Capital's portfolio in Q2 2026, its #290 holding.
Chicago Capital first reported a position in GSK in Q1 2019 and has held it in 30 quarters since.
Chicago Capital's GSK position peaked at $518K in Q4 2019.
439 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Chicago Capital's 13F filing for Q2 2026, filed 28 Jul 2026.